The personalised medicine company has now raised $83m altogether from investors including Cincinnati Children's Hospital Medical Center and Mayo Clinic.

Healthcare providers Mayo Clinic and Cincinnati Children’s Hospital Medical Center have contributed to a $15m round closed by US-based precision medicine developer Assurex Health.

The corporates invested alongside backers including Sequoia Capital, Claremont Creek Ventures and Cross Creek Advisors, all of which took part in a $30m round also featuring CincyTech, Allos Ventures and Danmar Capital in December 2014.

Assurex’s GeneSight technology uses genomic informatics to help make medicinal treatments more precise. GeneSight was developed using technology licensed from…